David Reid Cornblath
#113,348
Most Influential Person Now
David Reid Cornblath's AcademicInfluence.com Rankings
David Reid Cornblathbiology Degrees
Biology
#6414
World Rank
#9119
Historical Rank
Neuroscience
#777
World Rank
#810
Historical Rank

Download Badge
Biology
David Reid Cornblath's Degrees
- Bachelors Neuroscience University of Maryland, College Park
- Masters Neuroscience Johns Hopkins University
Why Is David Reid Cornblath Influential?
(Suggest an Edit or Addition)David Reid Cornblath's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Assessment of current diagnostic criteria for Guillain‐Barré syndrome (1990) (1821)
- Guillain-Barré syndrome (1994) (1073)
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision (2010) (1059)
- Peripheral neuropathy. (1982) (1016)
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome (1998) (849)
- DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). (2004) (793)
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection (1991) (773)
- Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. (1995) (730)
- The spectrum of neuropathy in diabetes and impaired glucose tolerance (2003) (682)
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (1990) (646)
- Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China (1993) (630)
- A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside (1988) (603)
- Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients (2005) (550)
- Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy (1998) (539)
- Epidermal nerve fiber density: normative reference range and diagnostic efficiency. (1998) (528)
- Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. (2011) (504)
- Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia. (2016) (494)
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma (1996) (478)
- A framework for diagnosing and classifying intensive care unit-acquired weakness. (2009) (471)
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision (2010) (467)
- EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy (2005) (435)
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision (2010) (410)
- Pathology of the motor‐sensory axonal Guillain‐Barré syndrome (1996) (409)
- Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy (1996) (399)
- Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome (1990) (397)
- The effect of systemically administered recombinant human nerve growth factor in healthy human subjects (1994) (391)
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society (2006) (370)
- Preceding infections, immune factors, and outcome in Guillain–Barré syndrome (2001) (369)
- Diagnosis and management of Guillain–Barré syndrome in ten steps (2019) (357)
- Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. (1995) (356)
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies (1994) (352)
- Quantitative sensory testing (2003) (350)
- HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology (1991) (335)
- Cutaneous innervation in sensory neuropathies (1995) (332)
- Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection (1987) (332)
- Small‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases (1998) (326)
- Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome (1999) (305)
- Tramadol for neuropathic pain. (2006) (301)
- Intraepidermal nerve fiber density in patients with painful sensory neuropathy (1997) (298)
- Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex (1988) (294)
- Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV‐1–infected individuals: Results from the multicenter AIDS cohort study (1989) (285)
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision (2010) (285)
- Serum antibodies to gangliosides in guillain‐barré syndrome (1988) (282)
- Total neuropathy score (1999) (277)
- Practice parameter: Immunotherapy for Guillain–Barré syndrome (2003) (268)
- Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresis (1988) (262)
- Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies (1990) (261)
- Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies (1999) (261)
- Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China (1991) (261)
- Supportive care for patients with Guillain-Barré syndrome. (2005) (258)
- Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome (1996) (258)
- Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases (2001) (255)
- Guillain-Barré syndrome: An update (2009) (246)
- Evidence-based guideline update: Plasmapheresis in neurologic disorders (2011) (237)
- Multifocal motor neuropathy: Response to human immune globulin (1993) (225)
- Neurotoxicity of Taxol. (1993) (222)
- Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. (1998) (214)
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society (2005) (211)
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. (2013) (202)
- Wallerian degeneration in human nerves: Serial electrophysiological studies (1992) (200)
- Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infection (1997) (194)
- Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. (1993) (194)
- Nerve conduction studies in amyotrophic lateral sclerosis (1992) (191)
- Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. (2000) (182)
- Thalidomide-induced neuropathy (2002) (177)
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (2018) (176)
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy * (2006) (176)
- Motor conduction studies in guillain‐barré syndrome: Description and prognostic value (1988) (170)
- Patterns of recovery in the Guillain-Barre syndromes (1997) (169)
- Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings (1988) (169)
- Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy (1999) (169)
- Conduction block in clinical practice (1991) (166)
- Modifying the Medical Research Council grading system through Rasch analyses (2011) (165)
- Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy (2008) (163)
- Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. (1997) (162)
- Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin‐associated glycoprotein (1991) (161)
- Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study (2009) (156)
- Regional variation of Guillain-Barré syndrome (2018) (156)
- Regional variation of Guillain-Barré syndrome (2018) (156)
- Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome (1998) (153)
- Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel (1992) (146)
- Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis (1988) (145)
- Neopterin and interferon‐gamma in serum and cerebrospinal fluid of patients with HIV‐associated neurologic disease (1991) (137)
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. (2014) (126)
- European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision (2021) (126)
- Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy (2009) (125)
- Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin (1991) (121)
- NEUROPHYSIOLOGICAL AND NEUROPSYCHOLOGICAL FUNCTION IN MERCURY-EXPOSED DENTISTS (1982) (120)
- Intensive management and treatment of severe Guillain‐Barré syndrome (1993) (116)
- A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patients (1987) (114)
- Multifocal motor neuropathy: Electrodiagnostic features (1994) (113)
- Inter‐ and intra‐examiner reliability of nerve conduction measurements in normal subjects (1991) (111)
- Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (2019) (108)
- Gracile tract degeneration in patients with sensory neuropathy and AIDS (1988) (106)
- Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice (2010) (104)
- Azathioprine in the treatment of myasthenia gravis (1984) (104)
- Clinical electrophysiology of infantile botulism (1983) (104)
- Relapse in Guillain‐Barré syndrome after treatment with human immune globulin (1993) (103)
- Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis (1989) (103)
- Autosomal dominant juvenile amyotrophic lateral sclerosis. (1999) (102)
- Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. (2013) (100)
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation (1994) (97)
- A prospective study of suramin-induced peripheral neuropathy. (1996) (95)
- Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy (1998) (94)
- A β‐subunit mutation in the acetylcholine receptor channel gate causes severe slow‐channel syndrome (1996) (94)
- Excitatory amino acids in amyotrophic lateral sclerosis: An update (1991) (93)
- Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: A clinical and electrophysiologic study (1999) (92)
- Assessment of thoracic paraspinal muscles in the diagnosis of ALS (1988) (90)
- Electrophysiological studies in the Guillain–Barré syndrome: Distinguishing subtypes by published criteria (1998) (86)
- Sensory nerve pathology in multifocal motor neuropathy (1996) (86)
- Electrophysiology in Gullian‐Barré syndeome (1990) (86)
- Head drop and camptocormia (2002) (85)
- Measures of chemotherapy‐induced peripheral neuropathy: a systematic review of psychometric properties (2010) (83)
- International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain‐Barré syndrome (2017) (79)
- Dominant GDAP1 mutations cause predominantly mild CMT phenotypes (2011) (78)
- Differentiating lower motor neuron syndromes (2016) (78)
- Low-dose zalcitabine-related toxic neuropathy (1996) (78)
- Diagnosis and Management of Peripheral Nerve Disorders (2001) (77)
- Macrophage responses in inflammatory demyelinating neuropathies (1990) (77)
- Quantitative analysis of endoneurial T-cells in human sural nerve biopsies (1990) (76)
- Neuropathological changes in early HIV‐1 dementia (1989) (74)
- COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations (2020) (74)
- Human immunodeficiency virus (HIV) infection and the nervous system (1989) (73)
- Characterization of cDNA and genomic DNA encoding SERCA1, the Ca(2+)-ATPase of human fast-twitch skeletal muscle sarcoplasmic reticulum, and its elimination as a candidate gene for Brody disease. (1995) (73)
- Patterns of Guillain-Barré syndrome in children (2007) (73)
- Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing? (1999) (73)
- Electrophysiology in Guillain-Barré syndrome. (1997) (72)
- Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. (1996) (71)
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society * (2006) (70)
- Physiologic-pathologic correlation in Guillain–Barré syndrome in children (2000) (67)
- Clinical applications of intravenous immunoglobulins in neurology (2009) (66)
- Recent advances in HIV neuropathy (2006) (66)
- European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision (2021) (65)
- Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy (1989) (64)
- High‐titer selective serum anti‐β‐tubulin antibodies in chronic inflammatory demyelinating polyneuropathy (1993) (63)
- All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. (2007) (63)
- Nerve conduction studies in adrenomyeloneuropathy. (1996) (62)
- Treatment of the neuromuscular complications of human immunodeficiency virus infection (1988) (60)
- Inter‐ and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy (1994) (59)
- An open‐label trial of rituximab (Rituxan®) in multifocal motor neuropathy (2010) (56)
- Changing outcome in inflammatory neuropathies (2014) (55)
- Chronic demyelinating polyneuropathy in systemic lupus erythematosus (1984) (54)
- Molecular Mimicry in Guillain‐Barré Syndrome a (1998) (49)
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. (2013) (49)
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. (2013) (49)
- Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings (2019) (48)
- Current treatment practice of Guillain-Barré syndrome (2019) (47)
- Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family (1990) (46)
- HIV‐1 infection and nervous system abnormalities among a cohort of intravenous drug users (1991) (45)
- Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial (2018) (43)
- A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance. (2013) (43)
- Conduction block in neuropathies with necrotizing vasculitis. (1991) (43)
- Monitoring azathioprine therapy in myasthenia gravis (1986) (42)
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). (2013) (42)
- Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study (2014) (41)
- Effect of MRI on treatment results or decision making in patients with lumbosacral radiculopathy referred for epidural steroid injections: a multicenter, randomized controlled trial. (2012) (41)
- Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders (1989) (40)
- A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34 (2000) (40)
- Transient conduction block following acute peripheral nerve ischemia (1985) (40)
- Surgical Decompression for Diabetic Sensorimotor Polyneuropathy (2007) (40)
- Conduction block in diabetic neuropathy (1991) (39)
- Compression syndromes due to hypertrophic nerve roots in hereditary motor sensory neuropathy type I (1989) (39)
- Identification of mononuclear cells in CSF of patients with HIV infection (1989) (38)
- Vestibular dysfunction in chronic inflammatory demyelinating Polyneuropathy (1996) (37)
- Campylobacter serology in patients with Chinese paralytic syndrome (1991) (37)
- Peripheral neuropathies in human immunodeficiency virus infection. (2004) (36)
- Therapeutic plasma exchange in neurology: 2012 (2013) (36)
- DIABETIC NEUROPATHY: DIAGNOSTIC METHODS — (2004) (35)
- Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial (2018) (35)
- Axoplasmic flow in cerebellar mossy and climbing fibers. (1973) (35)
- Anti-GD 1 a Antibody Is Associated with Axonal But Not Demyelinating Forms of Guillain-Barré Syndrome (1999) (34)
- Influence of malnutrition on developing rat peripheral nerves (1988) (34)
- Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease (1990) (32)
- Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. (2017) (32)
- Rasch‐built Overall Disability Scale for Multifocal motor neuropathy (MMN‐RODS©) (2015) (32)
- Electrodiagnosis of human colchicine myoneuropathy (1989) (32)
- Grip strength comparison in immune‐mediated neuropathies: Vigorimeter vs. Jamar (2015) (30)
- Open muscle biopsy in suspected myopathy: diagnostic yield and clinical utility (2010) (29)
- Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study (2019) (29)
- Creutzfeldt‐Jakob disease in a 20‐year‐old woman (1980) (28)
- Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison (2015) (28)
- Correlation of the patient's reported outcome Inflammatory‐RODS with an objective metric in immune‐mediated neuropathies (2016) (28)
- Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria. (2011) (28)
- The safety profile of dalfampridine extended release in multiple sclerosis clinical trials. (2012) (27)
- Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses (2015) (27)
- Tolerability of recombinant‐methionyl human neurotrophin‐3 (r‐metHuNT3) in healthy subjects (2000) (26)
- Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl. (2016) (26)
- Bortezomib and Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity. (2006) (25)
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial (2016) (25)
- Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome (1988) (25)
- Steroid‐responsive myeloneuropathy in a man dually infected with HIV‐1 and HTLV‐I (1990) (24)
- Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment (2013) (24)
- Manipulating the immune system with immune globulin. (1992) (23)
- Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc©) in patients with chemotherapy‐induced peripheral neuropathy (2015) (23)
- Disorders of neuromuscular transmission in infants and children (1986) (22)
- Erratum: A β-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome (Annals of Neurology (1996) 39 (712- 723)) (1996) (22)
- Stretch palsy of the spinal accessory nerve. Case report. (1990) (22)
- Stimulated single‐fiber electromyography in lambert‐eaton myasthenic syndrome (1991) (22)
- Rapid worsening of IgM anti‐MAG demyelinating polyneuropathy during rituximab treatment (2013) (22)
- Worsening of multifocal motor neuropathy during pregnancy (2002) (21)
- Pain in chemotherapy‐induced peripheral neurotoxicity (2017) (21)
- Poliomyelitis and flaviviruses (2003) (20)
- Peripheral Neuropathy in Diabetic Monkeys (1989) (19)
- Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study. (2019) (18)
- Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity (2019) (18)
- National Institute of Neurological Disorders and Stroke (NINDS): Advances in understanding and treating neuropathy, 24–25 October 2006; Bethesda, Maryland (2008) (17)
- Molecular insight into the asymmetric distribution of pathogenetic human mitochondrial DNA deletions. (1991) (17)
- Chapter 22 Peripheral neuropathies in human immunodeficiency virus infection (2004) (16)
- Spontaneous diabetes mellitus in a rhesus monkey: Neurophysiological studies (1989) (16)
- Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection (2021) (16)
- Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial (2021) (15)
- Laboratory testing in peripheral nerve disease. (1996) (15)
- Does ability to walk reflect general functionality in inflammatory neuropathies? (2016) (15)
- Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial (2021) (15)
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies (2019) (15)
- Autosomal dominant distal spinal muscular atrophy in four generations (1995) (14)
- Early invasive CNS aspergillosis. An easily missed diagnosis. (1991) (14)
- Early invasive CNS aspergillosis (2004) (14)
- Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP (2019) (14)
- Clinical and genetic description of a family with Charcot–Marie–Tooth disease type 1B from a transmembrane MPZ mutation (2004) (13)
- Alpha‐lipoic acid for diabetic peripheral neuropathy (2005) (13)
- Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review (2020) (13)
- Acetylcholine epilepsy: Relationship of surface concentration, chronicity of denervation, and focus size (1975) (12)
- Distribution of radioactivity from topically applied [H3]acetylcholine in relation to seizure (1976) (12)
- Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study (2019) (12)
- Toxic neuropathies: chemotherapy-induced peripheral neurotoxicity. (2019) (12)
- Conjugal amyotrophic lateral sclerosis (1993) (12)
- A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol (2018) (11)
- Paraproteinaemic Demyelinating Neuropathies (2010) (11)
- Patient‐reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study (2020) (11)
- IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG. (2018) (10)
- Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity (2021) (10)
- 231st ENMC International Workshop: International Standard for CIDP Registry and Biobank, Naarden, The Netherlands, 12–14 May 2017 (2017) (10)
- Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies (1986) (10)
- Acetylcholine epilepsy: modification of DC shift in chronically undercut cat cortex. (1974) (10)
- Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy (2020) (10)
- Werdnig‐Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance (1992) (10)
- APOE ε4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy (2005) (9)
- Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection (N4.002) (2017) (8)
- APOE epsilon4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy. (2005) (8)
- Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies (1994) (8)
- Treatment for guillain‐barré syndrome (2009) (8)
- Guillain-Barré syndrome – Authors' reply (2006) (8)
- 230th ENMC International Workshop: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017 (2017) (7)
- Mononuclear cell typing in inflammatory demyelinating polyneuropathy nerve biopsies (1987) (7)
- Perioperative bilateral median neuropathy. (2002) (7)
- Peripheral Nerve Vasculitis Presenting as Complex Regional Pain Syndrome (2008) (7)
- Yield of next‐generation neuropathy gene panels in axonal neuropathies (2019) (6)
- Peripheral neuropathies in human immunodeficiency virus type 1 infection (1995) (6)
- A novel HSPB1 mutation associated with a late onset CMT2 phenotype: Case presentation and systematic review of the literature (2020) (6)
- Guillain-Barré syndrome in times of pandemics (2020) (6)
- Peroxisomal disorders. (1991) (6)
- Incidence of irritable electromyography in inflammatory myopathy. (1999) (6)
- Gomez, C. M. et al. A -subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann. Neurol. 39, 712-723 (1996) (5)
- Skin biopsy and small fibre neuropathies: facts and thoughts 30 years later (2022) (5)
- Nerve conduction studies in diabetic neuropathy (1995) (5)
- Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome. (1992) (5)
- Intact Bell's phenomenon in a patient with myasthenia gravis and upward gaze paresis. (1989) (4)
- Response to comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy (2006) (4)
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study (2017) (4)
- The electrophysiology of axonal and demyelinating polyneuropathies. (1996) (4)
- GUILLAIN-BARRE SYNDROME IN NORTHERN CHINA. THE SPECTRUM OF NEUROPATHOLOGICAL CHANGES IN CLINICALLY DEFINED CASES. AUTHORS'S REPLIES (1996) (4)
- Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy (2022) (3)
- The value of rectus abdominal muscle electromyography. (1987) (3)
- Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values (2022) (3)
- Treatment for human immunodeficiency virus-related distal symmetrical polyneuropathy (2003) (3)
- Chapter 34 Guillain-Barré syndrome (2006) (3)
- An International Perspective on Preceding Infections in Guillain-Barré Syndrome (2022) (3)
- Chapter 25. Paraproteinaemic Demyelinating Neuropathy (2008) (3)
- Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values (2022) (3)
- Chemotherapy‐induced peripheral neurotoxicity: Facts, needs and future directions (2019) (2)
- Inflammatory demyelinating polyneuropathies in human immunodeficiency virus infection (1986) (2)
- Meeting Report: 2013 Peripheral Nerve Society Biennial Meeting, Saint‐Malo, France, June 29–July 3, 2013 (2013) (2)
- X-linked adrenoleukodystrophy: Epidemiology, pathogenesis and therapy (1990) (2)
- A recurrent MORC2 mutation causes Charcot‐Marie‐Tooth disease type 2Z (2021) (2)
- Creutzfeldt‐Jakob disease in a 20‐year‐old woman (1981) (2)
- Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study (2021) (2)
- Fatigue in chronic inflammatory demyelinating polyradiculoneuropathy (2020) (2)
- Neuropathy in grout workers (2004) (2)
- The Guillain-Barré syndrome and human immunodeficiency virus. (1989) (2)
- Quantitative sensory testing Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (2003) (1)
- Clinical electromyography: 2nd edn. - William F. Brown and Charles F. Bolton (Eds.) (Heinemann, Boston, 1993, 810pp., Price: US $150.00) (1997) (1)
- Subacute sensory neuronopathy and cancer: the identification of paraneoplastic syndromes (2020) (1)
- [Evidence based guidelines. Diagnosis and management of Guillain-Barré syndrome in ten steps]. (2021) (1)
- Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience (2019) (1)
- The Jack Griffin Memorial Symposium. (2012) (1)
- Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS (2022) (1)
- Guillain-Barré syndrome: the evolution of therapy (1994) (1)
- Electrophysiological Testing in Patients with Chronic Inflammatory Demyelinating Polyneuropathy Treated with Subcutaneous Immunoglobulin: The PATH Study (P1.433) (2018) (1)
- DS3.1 Neuromuscular manifestations of HIV infection (2006) (1)
- Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy (2021) (1)
- Letter from new Editor‐in‐Chief (2007) (1)
- Peripheral nerve and spinal cord disease in human retrovirus infections (1990) (1)
- Abnormal nerve function in dentists with elevated tissue mercury levels (1982) (1)
- Plenary I : How Do We Measure Up ? Quantitation in EDX and Clinical Practice (2012) (1)
- Comment on research report by Gruson and colleagues, this issue (2011) (0)
- IVIG: Effective Treatment for Sensory Neuronopathy in Sjögren's? (2003) (0)
- 77. Bortezomib and thalidomide-induced subacute demyelinating polyneuropathy (2009) (0)
- Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study (2019) (0)
- Abstracts of the 2008 Inflammatory Neuropathy Consortium (INC) Meeting (2008) (0)
- Cerebrospinal Fluid Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome. (2023) (0)
- 20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study) (2020) (0)
- IN71-FR-01 Multifocal motor neuropathy (2009) (0)
- Wireless, Bedside, Patient Outcomes Data Collection Obtained During Home Infusions (CareExchange TM ) (2012) (0)
- Intravenous human immune globulin in Guillain-Barré syndrome (1997) (0)
- Demylinating Peripheral Neuropathy and Lymphoplasmacytic Lymphoma (2010) (0)
- Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and Colleagues. (2022) (0)
- Erratum: Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34 (American Journal of Human Genetics (March) 62 (633-640)) (1998) (0)
- 21. Exposure-response of serum IgG levels and INCAT scores in CIDP patients receiving subcutaneous immunoglobulin (IgPro20) (2020) (0)
- Peripheral nerve safety measures in a multicenter, double-blind, randomized, placebo-controlled, dose-ranging study of fulranumab in patients with painful diabetic neuropathy (2013) (0)
- A 68-year-old man with diabetic peripheral neuropathy (2004) (0)
- Reply (1998) (0)
- 19. Pharmacokinetic modelling and simulation of flexible dosing regimens of subcutaneous immunoglobulin (IgPro20) in CIDP patients (2020) (0)
- Panel discussion of case study 1 (2005) (0)
- 046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP) (2018) (0)
- Format for case reports of known CMT genes that merit reporting (2010) (0)
- PATH (polyneuropathy and treatment with Hizentra ®: a randomized, controlled trial of Hizentra ®, a 20% immunoglobulin preparation for subcutaneous administration, in patients with chronic inflammatory demyelinating polyradiculoneuropathy (2012) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- Inflammatory Neuropathy Consortium: Report of a meeting held on 4–6 July 2008, Bâtiment Babinski, Hôpital de la Salpêtrière, Paris, France (2008) (0)
- Reply (1993) (0)
- Creutzfeldt‐Jakob disease in a 20‐year‐old woman (1981) (0)
- IgM Anti MAG± Peripheral Neuropathy (IMAGiNe) Study Protocol: An international, observational, prospective registry of patients with IgM M-protein Peripheral Neuropathies. (2023) (0)
- Conduction Abnormalities in ALS and in Diabetes Differ (2002) (0)
- Efficacy and safety of intravenous immunoglobulin IgPro10 in CIDP: Combination of PRIMA and PATH studies (2018) (0)
- Featured Cover (2021) (0)
- Principles of Immunomodulatory Therapy (1994) (0)
- Reply (1996) (0)
- Report from the Satellite Meeting of the Peripheral Nerve Society in Sydney, Australia, July 5–7, 2010 (2010) (0)
- Chapter 15 Principles of Immunomodulatory Therapy (1994) (0)
- Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy (2022) (0)
- 2007 impact factor for the Journal of the Peripheral Nervous System: 2.943 (2008) (0)
- Books Received (2001) (0)
- Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016) (2013) (0)
- Into Mechanisms Causing Neuronal Dysfunction and Death. It Diagnosis and Management of Peripheral Nerve Disorders Edited (0)
- S-3-3 Multifocal motor neuropathy: reflections over 7 years (1995) (0)
- Erratum: Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS©) (Journal of the Peripheral Nervous System (2015) 20 (296-305)) (2016) (0)
- Supplementary tables/figures and referecences to A Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy Induced Peripheral Neurotoxicity. (2021) (0)
- Intravenous versus subcutaneous immunoglobulin – Authors' reply (2018) (0)
- Guillain-Barré Syndrome with an Atypical Course (2010) (0)
- 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment (2020) (0)
- A Phase 2/3 Placebo-Controlled, Parallel Group, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: the ARISE study (P14-8.006) (2023) (0)
- A recurrent MORC2 mutation causes CMT2Z. (2021) (0)
- Letters to the editor (1991) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- THE INFLAMMATORY NEUROPATHY CONSORTIUM REGISTRY FOR MULTIFOCAL MOTOR NEUROPATHY (2011) (0)
- Introduction (2012) (0)
- P33 - The design of a phase III trial to confirm efficacy and safety of PXT3003 for the treatment of Charcot-Marie-Tooth Disease Type 1A (2015) (0)
- Reply (1991) (0)
- Letters to the editor (1987) (0)
- Provider Perceptions Of Clinical Neuropathy Examination Usefulness (2013) (0)
- PLASMA EXCHANGE IN GUILLAIN-BARRE SYNDROME AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (1996) (0)
- 17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study (2020) (0)
- Suramin-induced demyelinating neuropathy (1996) (0)
- BS7 Demyelinating peripheral neuropathy (2006) (0)
- Efficacy and Safety of Intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): the PRIMA and PATH studies (P1.153) (2018) (0)
- Reply (1994) (0)
- Clinical applications of neurotropic factors. Edited by Stuart Apfel, Philadelphia, Lippincott‐Raven, 1997 209 pp, illustrated $95.00 (1998) (0)
- Academy of disorders : Report of the Therapeutics and Technology Evidence-based guideline update : Plasmapheresis in neurologic (2011) (0)
- CURRENT DIAGNOSTIC CRITERIA FOR GUILLAIN-BARRE SYNDROME. AUTHRO'S REPLY (1991) (0)
- Chapter 24. Multifocal Motor Neuropathy (2008) (0)
- Maybe myopathic EMG but not myopathy (2021) (0)
- DIFFERENT PATTERNS OF PNS DEMYELINATION OCCUR IN HIV INFECTION: 242 (1989) (0)
- Chapter 23. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David Reid Cornblath?
David Reid Cornblath is affiliated with the following schools: